Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the ...

North America continues to dominate the paediatric and neonatal testing kits market, driven by high birth rates, advanced ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo's smartwatches infringe two of its design patents as part of a broader intellectual property ...

The $250 (yep, there’s no missing ‘M’ from the end of that number) Apple was awarded in its patent infringement case against Masimo might seem amusing – as John Gruber wryly noted ...

Masimo has obtained an import ban for an Apple Watch feature in the USA. Apple sued back and won a Pyrrhic victory. A new chapter has been added to the conflict between Apple and medical ...

A jury in Delaware awarded Apple $250, concluding that Masimo's older smartwatch designs infringed on Apple's design patents. The jury determined the infringement was intentional, but the verdict ...

A Delaware jury has found health tech company Masimo guilty of infringing Apple’s Apple Watch patents on health technology, but limited it to only older smartwatch models that are no longer sold, and ...